Antibiotice S.A. (BVB:ATB)
Romania · Delayed Price · Currency is RON 2.140
-0.005 (-0.23%)
At close: Aug 12, 2026
Antibiotice Ratios and Metrics
Market cap in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,437 | 1,645 | 1,719 | 937 | 380 | 407 | |
Market Cap Growth | -17.85% | -4.30% | 83.51% | 146.47% | -6.60% | 24.69% |
Enterprise Value | 1,748 | 1,890 | 1,811 | 1,011 | 462 | 548 |
Last Close Price | 2.14 | 2.45 | 2.54 | 1.35 | 0.54 | 0.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 45.34 | 31.77 | 16.82 | 11.55 | 7.38 | 13.59 |
Forward PE | - | 11.73 | 11.73 | 11.73 | 11.73 | 11.73 |
PS Ratio | 2.25 | 2.49 | 2.50 | 1.52 | 0.75 | 1.07 |
PB Ratio | 1.52 | 1.77 | 1.92 | 1.11 | 0.51 | 0.67 |
P/TBV Ratio | 1.57 | 1.82 | 1.97 | 1.12 | 0.52 | 0.71 |
P/FCF Ratio | - | - | - | 23.75 | 4.87 | 26.44 |
P/OCF Ratio | 21.80 | 22.71 | 18.06 | 7.65 | 3.29 | 9.15 |
PEG Ratio | - | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.74 | 2.86 | 2.63 | 1.64 | 0.91 | 1.45 |
EV/EBITDA Ratio | 16.81 | 15.12 | 11.90 | 8.07 | 4.84 | 9.34 |
EV/EBIT Ratio | 36.18 | 26.71 | 16.90 | 10.38 | 6.34 | 16.01 |
EV/FCF Ratio | - | - | - | 25.64 | 5.91 | 35.63 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.33 | 0.25 | 0.16 | 0.08 | 0.11 | 0.24 |
Debt / EBITDA Ratio | 3.01 | 1.90 | 0.94 | 0.55 | 0.85 | 2.47 |
Debt / FCF Ratio | - | - | - | 1.75 | 1.04 | 9.41 |
Net Debt / Equity Ratio | 0.33 | 0.24 | 0.16 | 0.08 | 0.11 | 0.24 |
Net Debt / EBITDA Ratio | 2.99 | 1.82 | 0.92 | 0.54 | 0.83 | 2.43 |
Net Debt / FCF Ratio | -2.93 | -3.24 | -38.76 | 1.71 | 1.01 | 9.27 |
Asset Turnover | 0.45 | 0.49 | 0.57 | 0.58 | 0.54 | 0.43 |
Inventory Turnover | 1.25 | 1.46 | 1.53 | 1.53 | 1.51 | 1.37 |
Quick Ratio | 1.09 | 1.27 | 1.22 | 1.24 | 1.50 | 1.39 |
Current Ratio | 1.83 | 2.02 | 2.02 | 2.11 | 2.57 | 1.93 |
Return on Equity (ROE) | 3.39% | 5.67% | 11.74% | 10.21% | 7.65% | 5.07% |
Return on Assets (ROA) | 2.13% | 3.31% | 5.54% | 5.73% | 4.84% | 2.44% |
Return on Invested Capital (ROIC) | 3.39% | 5.55% | 10.90% | 9.95% | 7.32% | 4.57% |
Return on Capital Employed (ROCE) | 4.10% | 6.20% | 10.30% | 10.30% | 8.60% | 4.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.21% | 3.15% | 5.95% | 8.66% | 13.55% | 7.36% |
FCF Yield | -7.40% | -4.27% | -0.21% | 4.21% | 20.55% | 3.78% |
Dividend Yield | 1.67% | 1.46% | 0.81% | 6.16% | 1.46% | 0.56% |
Payout Ratio | 50.26% | 30.81% | 47.13% | 6.70% | 6.66% | 7.02% |
Total Shareholder Return | 1.68% | 1.46% | 0.81% | 6.16% | 1.46% | 0.56% |